Product Information
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.1386 per EA under NDC 60687089001. Its NADAC has been published 50 times since Sep 10, 2025.
FDA first approved this application on Oct 6, 2020. Its Orange Book therapeutic-equivalence code is AA.
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET
diphenoxylate hydrochloride and atropine sulfateStrength
.025; 2.5 mg/1; mg/1
Manufacturer
American Health PackagingNDC
60687089001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213335FDA Approved
10/6/2020
TE Code
AA
On Market Since
8/1/2025
Pharmacological Classes
Price Statistics
The NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has been published 50 times since Sep 10, 2025, and over the history we have for it it has declined 24.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1386 per EA |
|---|---|
| All-time high | $0.1837 (Sep 10, 2025) |
| All-time low | $0.1371 (Jul 22, 2026) |
| 52-week high | $0.1837 |
| 52-week low | $0.1371 |
| Median price | $0.1560 |
| Average price | $0.1550 |
| Largest weekly change | -4.8% (Oct 22, 2025) |
| Weeks tracked | 50 |
| Tracking since | Sep 10, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET, manufactured by American Health Packaging, is $0.1386 per EA (NDC 60687089001), effective Aug 19, 2026.
How has the price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET changed over time?
Over the history we have for it, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has declined 24.6%. It has been tracked across 50 weekly CMS publications since Sep 10, 2025.
What are the highest and lowest recorded NADAC prices for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
Since Sep 10, 2025, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has ranged from a low of $0.1371 (Jul 22, 2026) to a high of $0.1837 (Sep 10, 2025), with a median of $0.1560 per EA.
Are there cheaper alternatives to DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET (NDC 60687089001) is labeled by American Health Packaging, and CMS classifies it as a generic product.